Cangene (FRA:YGE) Accounts Payable & Accrued Expense : €17.43 Mil (As of Oct. 2013)

View and export this data going back to . Start your Free Trial

What is Cangene Accounts Payable & Accrued Expense?

Cangene's quarterly accounts payable & accrued expense declined from Apr. 2013 (€17.42 Mil) to Jul. 2013 (€15.74 Mil) but then increased from Jul. 2013 (€15.74 Mil) to Oct. 2013 (€17.43 Mil).

Cangene's annual accounts payable & accrued expense declined from Jul. 2011 (€12.84 Mil) to Jul. 2012 (€11.79 Mil) but then increased from Jul. 2012 (€11.79 Mil) to Jul. 2013 (€15.74 Mil).

Cangene Accounts Payable & Accrued Expense Historical Data

The historical data trend for Cangene's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Accounts Payable & Accrued Expense Chart

Cangene Annual Data

Trend

Jul04

Jul05

Jul06

Jul07

Jul08

Jul09

Jul10

Jul11

Jul12

Jul13

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

21.15

19.35

12.84

11.79

15.74

Cangene Quarterly Data
	Jan09	Apr09	Jul09	Oct09	Jan10	Apr10	Jul10	Oct10	Jan11	Apr11	Jul11	Oct11	Jan12	Apr12	Jul12	Oct12	Jan13	Apr13	Jul13	Oct13
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															12.04	12.91	17.42	15.74	17.43

Cangene Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Cangene (FRA:YGE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.cangene.com

Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines